Side effects - Heart - Chronic Myeloid Leukemia - CML
Pressure check in both arms catches artery disease (peripheral artery disease)
January 31, 2012, MyHealthNewsDaily Staff
Nilotinib treatment?associated peripheral artery disease and sudden death: Yet another reason to stick to imatinib as front?line therapy for chronic myelogenous leukemia
April 23, 2011, CMLHope.com
A prospective evaluation of cardiac function in patients with chronic myeloid leukaemia treated with imatinib
August 2010, Leukemia Research
Reversible Cardiotoxicity with tyrosine kinase inhibitors
February 2010, Clinical advances In Hematology & Oncology
Effect of nilotinib on the pharmacokinetics and pharmacodynamics of warfarin
2009 ASCO annual meeting
Tyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemia
July 2009, Journal Blood
Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia
August 2008, Journal Blood
Leukemia Drug May Improve Stroke Treatment
June 2008, WebMed
Gleevec – Same Drug, Twin Benefits?
June 2008, The Money Times
Leukemia pill may improve stroke treatment: study
June 2008, Canada.com
Cancer Drug Gleevec Could Fight Stroke
June 2008, HealthDay - eVitamine
Cardiac Events with Gleevec
May 6, 2008, LawsuitGuru VIDEO
Study Finds Heart Failure Is Rare Among Leukemia Patients on Imatinib
September 2007, MDAnderson Cancer center
Cardiotoxicity of imatinib is "a surprise"
July 2006, Heartwire
